PriSUD-Nordic-Diagnosing and Treating Substance Use Disorders in the Prison Population: Protocol for a Mixed Methods Study.

criminal justice epidemiology harm reduction mixed methods prison substance use disorders treatment

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
23 Mar 2022
Historique:
received: 30 11 2021
accepted: 06 12 2021
entrez: 23 3 2022
pubmed: 24 3 2022
medline: 24 3 2022
Statut: epublish

Résumé

A large proportion of the prison population experiences substance use disorders (SUDs), which are associated with poor physical and mental health, social marginalization, and economic disadvantage. Despite the global situation characterized by the incarceration of large numbers of people with SUD and the health problems associated with SUD, people in prison are underrepresented in public health research. The overall objective of the PriSUD (Diagnosing and Treating Substance Use Disorders in Prison)-Nordic project is to develop new knowledge that will contribute to better mental and physical health, improved quality of life, and better life expectancies among people with SUD in prison. PriSUD-Nordic is based on a multidisciplinary mixed method approach, including the methodological perspectives of both quantitative and qualitative methods. The qualitative part includes ethnographic fieldwork and semistructured interviews. The quantitative part is a registry-based cohort study including national registry data from Norway, Denmark, and Sweden. The national prison cohorts will comprise approximately 500,000 individuals and include all people imprisoned in Norway, Sweden, and Demark during the period from 2000 to 2019. The project will investigate the prison population during three different time periods: before imprisonment, during imprisonment, and after release. PriSUD-Nordic was funded by The Research Council of Norway in December 2019, and funding started in 2020. Data collection is ongoing and will be completed in the first quarter of 2022. Data will be analyzed in spring 2022 and the results will be disseminated in 2022-2023. The PriSUD-Nordic project has formal ethical approval related to all work packages. PriSUD-Nordic will be the first research project to investigate the epidemiology and the lived experiences of people with SUD in the Nordic prison population. Successful research in this field will have the potential to identify significant areas of benefit and will have important implications for ongoing policy related to interventions for SUD in the prison population. DERR1-10.2196/35182.

Sections du résumé

BACKGROUND BACKGROUND
A large proportion of the prison population experiences substance use disorders (SUDs), which are associated with poor physical and mental health, social marginalization, and economic disadvantage. Despite the global situation characterized by the incarceration of large numbers of people with SUD and the health problems associated with SUD, people in prison are underrepresented in public health research.
OBJECTIVE OBJECTIVE
The overall objective of the PriSUD (Diagnosing and Treating Substance Use Disorders in Prison)-Nordic project is to develop new knowledge that will contribute to better mental and physical health, improved quality of life, and better life expectancies among people with SUD in prison.
METHODS METHODS
PriSUD-Nordic is based on a multidisciplinary mixed method approach, including the methodological perspectives of both quantitative and qualitative methods. The qualitative part includes ethnographic fieldwork and semistructured interviews. The quantitative part is a registry-based cohort study including national registry data from Norway, Denmark, and Sweden. The national prison cohorts will comprise approximately 500,000 individuals and include all people imprisoned in Norway, Sweden, and Demark during the period from 2000 to 2019. The project will investigate the prison population during three different time periods: before imprisonment, during imprisonment, and after release.
RESULTS RESULTS
PriSUD-Nordic was funded by The Research Council of Norway in December 2019, and funding started in 2020. Data collection is ongoing and will be completed in the first quarter of 2022. Data will be analyzed in spring 2022 and the results will be disseminated in 2022-2023. The PriSUD-Nordic project has formal ethical approval related to all work packages.
CONCLUSIONS CONCLUSIONS
PriSUD-Nordic will be the first research project to investigate the epidemiology and the lived experiences of people with SUD in the Nordic prison population. Successful research in this field will have the potential to identify significant areas of benefit and will have important implications for ongoing policy related to interventions for SUD in the prison population.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/35182.

Identifiants

pubmed: 35320114
pii: v11i3e35182
doi: 10.2196/35182
pmc: PMC8987966
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e35182

Informations de copyright

©Anne Bukten, Nicoline Toresen Lokdam, Ingeborg Skjærvø, Thomas Ugelvik, Svetlana Skurtveit, Roman Gabrhelík, Torbjørn Skardhamar, Ingunn Olea Lund, Ingrid Amalia Havnes, Eline Borger Rognli, Zheng Chang, Seena Fazel, Christine Friestad, Morten Hesse, Johan Lothe, Gerhard Ploeg, Anja J E Dirkzwager, Thomas Clausen, Christian Tjagvad, Marianne Riksheim Stavseth. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 23.03.2022.

Références

World Psychiatry. 2017 Oct;16(3):299-307
pubmed: 28941090
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
Lancet. 2011 Mar 12;377(9769):956-65
pubmed: 21093904
Stat Med. 2019 Feb 28;38(5):751-777
pubmed: 30347461
BMJ Open. 2021 May 10;11(5):e047028
pubmed: 33972343
Health Justice. 2018 Oct 15;6(1):19
pubmed: 30324532
Health Aff (Millwood). 2014 Jul;33(7):1163-70
pubmed: 25006142
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
World Psychiatry. 2017 Jun;16(2):213-214
pubmed: 28498572
Lancet. 2016 Sep 17;388(10050):1202-14
pubmed: 27427457
Res Involv Engagem. 2018 Dec 13;4:49
pubmed: 30564459
Lancet. 2012 Oct 27;380(9852):1491-7
pubmed: 22981903
Lancet Psychiatry. 2016 Jun;3(6):535-43
pubmed: 27086134
BMJ. 2009 Feb 23;338:b375
pubmed: 19237405
Eur Addict Res. 2021;27(3):179-188
pubmed: 33321498
Addiction. 2017 Oct;112(10):1725-1739
pubmed: 28543749
Bull World Health Organ. 2011 Sep 1;89(9):689-94
pubmed: 21897490
Epidemiol Rev. 2018 Jun 1;40(1):4-11
pubmed: 29860342
Int J Offender Ther Comp Criminol. 2014 Aug;58(8):914-30
pubmed: 23782704
Addiction. 2011 Jan;106(1):32-51
pubmed: 21054613
BMJ. 2010 Feb 05;340:c221
pubmed: 20139215
Eur J Public Health. 2010 Dec;20(6):653-8
pubmed: 20123684
Subst Abuse. 2015 Oct 29;9(Suppl 2):33-8
pubmed: 26560694

Auteurs

Anne Bukten (A)

Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway.
Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Nicoline Toresen Lokdam (NT)

Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway.
Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Ingeborg Skjærvø (I)

Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway.
Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Thomas Ugelvik (T)

Department of Criminology and Sociology of Law, University of Oslo, Oslo, Norway.

Svetlana Skurtveit (S)

Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway.
Department of Mental Disorders, Division of Mental and Physical Health, The Norwegian Institute of Public Health, Oslo, Norway.

Roman Gabrhelík (R)

Department of Addictology, First Faculty of Medicine, Charles University, Prague, Czech Republic.

Torbjørn Skardhamar (T)

Department of Sociology and Human Geography, University of Oslo, Oslo, Norway.

Ingunn Olea Lund (IO)

Department of Mental Disorders, Division of Mental and Physical Health, The Norwegian Institute of Public Health, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.

Ingrid Amalia Havnes (IA)

Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Adult Psychiatry Unit, University of Oslo, Oslo, Norway.

Eline Borger Rognli (EB)

Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Zheng Chang (Z)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Seena Fazel (S)

Department of Psychiatry, University of Oxford, Oxford, United Kingdom.

Christine Friestad (C)

Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
University College of Norwegian Correctional Service, Lillestrøm, Norway.

Morten Hesse (M)

Center for Alcohol and Drug Research, Aarhus University, Aarhus, Denmark.

Johan Lothe (J)

WayBack, Foundation for Life After Imprisonment, Oslo, Norway.

Gerhard Ploeg (G)

Directorate of Norwegian Correctional Service, Lillestrøm, Norway.

Anja J E Dirkzwager (AJE)

Netherlands Institute for the Study of Crime and Law Enforcement, Amsterdam, Netherlands.

Thomas Clausen (T)

Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway.

Christian Tjagvad (C)

Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway.

Marianne Riksheim Stavseth (MR)

Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway.
Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Classifications MeSH